Articles about Zydus Cadila

The COVID-19 vaccine manufacturers in India are reportedly waiting for "more data" on the new coronavirus variant, Omicron, to assess the efficacy of their vaccines.

The indigenous COVID-19 vaccine developed by Zydus Cadila, called ZyCoV-D, is likely to be rolled out in the next two weeks.

Several antiviral drugs are being developed and tested for COVID-19 treatment as scientists around the world race to find new methods to fight the pandemic and ease the burden on hospitals.

The National Technical Advisory Group on Immunization (NTAGI) will soon hold a meeting to devise a roadmap for introducing Zydus Cadila's COVID-19 vaccine in the inoculation drive and prioritizing beneficiaries focusing on those aged 12-18 years with comorbidities.

After receiving emergency use approval for its COVID-19 vaccine, Zydus Cadila will now submit an application to start vaccine trials for children aged 3-12 years, Managing Director Dr. Sharvil Patel said Saturday.

Zydus Cadila's three-dose coronavirus vaccine has received the emergency use authorization from India's top drug regulator, becoming the sixth jab to get the nod in the country.

The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting an emergency use authorization (EUA) to ZyCoV-D, the three-dose COVID-19 vaccine developed by Zydus Cadila, on Friday.

India will likely have a COVID-19 vaccine for children by next month, Dr. Priya Abraham said in an interview.

India's second indigenous COVID-19 vaccine, developed by Zydus Cadila, is reportedly likely to get emergency use approval (EUA) this week.

India will likely have its first coronavirus vaccine for children by September, said Dr. Randeep Guleria, the chief of Delhi's All India Institute of Medical Sciences (AIIMS).

Coronavirus vaccination for children with the Zydus Cadila vaccine will start by September, said Dr. NK Arora, the chief of National Expert Group on Vaccine Administration.

Zydus Cadila, the Gujarat-based drug firm, has applied for the Emergency Use Authorization (EUA) of its COVID-19 vaccine to the Drugs Controller General of India (DCGI), the company said today.

Zydus Cadila, the Gujarat-based drug firm, will next week apply for the emergency use authorization (EUA) of its COVID-19 vaccine in India, company sources told the media, adding it has apprised the government of its intention.

Indian pharmaceutical firm Zydus Cadila has sought permission from the Drugs Controller General of India (DCGI) to conduct human clinical trials of its antibody cocktail meant to treat mild COVID-19 patients.

The Drugs Controller General of India (DCGI) on Friday gave approval for the emergency use of Zydus Cadila's Hepatitis C drug "Virafin" for the treatment of moderate coronavirus infection in adults.

India's friendly neighboring nations trained over 100 experts to strengthen capacities in their countries for facilitating phase-3 clinical trials of the Indian COVID-19 vaccine, a senior official of the Department of Biotechnology said.

Prime Minister Narendra Modi is set to chair an all-party meeting this Friday to review the COVID-19 situation in India, according to reports.

The CEO of the Serum Institute of India (SII), Adar Poonawalla, on Saturday said that the company will seek the emergency-use authorization of the coronavirus vaccine 'Covishield' soon.

Prime Minister Narendra Modi on Saturday embarked on a three-city tour to review the development of COVID-19 vaccines.

Prime Minister Narendra Modi will visit three cities today to review the coronavirus vaccine development and manufacturing process, his office revealed.

Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.

It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.

Although the coronavirus outbreak in India has started to slow down, the country remains the second worst-hit in the world.

The Indian government is planning to provide vaccines to roughly 25 crore people by July 2021, Union Health Minister Dr. Harsh Vardhan said on Sunday.

A vaccine for COVID-19 is likely to be ready by early 2021, a leading vaccine scientist has said. However, the real challenge for India would be conducting a vaccination drive for its population of 1.3 billion.

As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.

Amid surging COVID-19 cases and questions over the peak for India, the government has started working towards procuring a vaccine.

With the world counting on a coronavirus vaccine to save it from the disease that has taken 763,572 lives so far, Prime Minister Narendra Modi on Saturday said India is ready to mass-produce the vaccine once it's developed.

In a major development, Zydus Cadila has launched the cheapest generic version of Remdesivir, the antiviral drug being used to treat COVID-19, in India.

Israel says it has an 'excellent' vaccine in hand to prevent COVID-19, the novel coronavirus disease.

In the updates since last night, both Facebook and Twitter launched a crackdown on a misleading post from US President Donald Trump.

Indian drug company Zydus Cadila has completed early-stage human trials with its indigenously developed COVID-19 vaccine.

In the updates since last night, Apple unveiled a refreshed 27-inch iMac.

Prime Minister Narendra Modi is likely to convene a virtual meeting with Chief Ministers of all states on July 27, Monday, to discuss the coronavirus situation in their respective regions and the steps taken to mitigate the effect of the biggest health crisis in a century.

In the race to develop a vaccine for the novel coronavirus disease (COVID-19), two pharma companies are leading the way from India - Bharat Biotech and Zydus Cadila.

As the coronavirus outbreak continues to surge worldwide, efforts to develop a vaccine have been expedited.

With more than 5.3 lakh deaths and 1.14 crore infections, the COVID-19 pandemic continues to grow worse around the world.

India is picking up pace to develop a preventive vaccine for COVID-19, the novel coronavirus disease.

India has opened up, but the pandemic is not slowing down.

In a major step forward, the Indian Council of Medical Research and National Institute of Virology have jointly announced the development of COVID KAVACH ELISA, the first indigenous antibody detection kit for COVID-19.